Benzinga | Dec 15, 2021 06:25AM EST

JMP Securities Initiates Coverage On Quoin Pharmaceuticals with Market Outperform Rating, Announces Price Target of $8

JMP Securities analyst Jason Butler initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Market Outperform rating and announces Price Target of $8.